companydata.dkcompanydata.dk

Freya Biosciences License ApS: Financial statements 2023

CVR: 41372079

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Freya Biosciences License ApS (CVR 41372079) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -24,000 and a net result of DKK -24,000 compared with DKK -48,000 the year before. Equity in the 2023 report amounted to DKK 195,000. The solvency ratio was 75.9%.

Gross Profit
DKK -24,000
Profit/Loss
DKK -24,000
Equity
DKK 195,000
Total Assets
DKK 257,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--24K-24K195K-
2022--48K-48K105K-
20210-38K-38K19K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Freya Biosciences License ApS: The 2022 annual report is outJul 3, 2023

Freya Biosciences License ApS has published its annual report for 2022. Gross profit came to DKK -48,000, and the net result was DKK -48,000.

Claudia Maria Colciago joins the board of Freya Biosciences License ApSFeb 20, 2023

As of February 20, 2023, Claudia Maria Colciago has joined the board of directors of Freya Biosciences License ApS.

Registered as owner of Freya Biosciences License ApSFeb 20, 2023

As of February 20, 2023, is registered as an owner of Freya Biosciences License ApS with an ownership share of 20%.

Registered as owner of Freya Biosciences License ApSFeb 20, 2023

As of February 20, 2023, is registered as an owner of Freya Biosciences License ApS with an ownership share of 5%.

About Freya Biosciences License ApS

Freya Biosciences License ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. In 2025, the company reported a gross profit of DKK -14,000 and a net result of DKK -14,000 compared with DKK -30,358 the year before. Equity in the 2025 report amounted to DKK 357,000.

Source: annual report 2025, Danish Business Authority

Other financial years